Takeda Pharmaceutical Current Ratio 2007-2020 | TAK

Current and historical current ratio for Takeda Pharmaceutical (TAK) from 2007 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Takeda Pharmaceutical current ratio for the three months ending September 30, 2020 was 1.51.
Takeda Pharmaceutical Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-09-30 $24.30B $16.07B 1.51
2020-06-30 $23.02B $18.89B 1.22
2020-03-31 $22.72B $20.02B 1.14
2019-12-31 $23.19B $19.57B 1.19
2019-09-30 $22.08B $15.20B 1.45
2019-06-30 $26.68B $18.26B 1.46
2018-12-31 $23.76B $7.76B 3.06
2018-06-30 $9.60B $6.75B 1.42
2017-06-30 $11.44B $8.46B 1.35
2016-06-30 $13.70B $7.65B 1.79
2015-06-30 $12.07B $8.29B 1.46
2015-03-31 $13.83B $9.25B 1.50
2014-12-31 $14.99B $7.37B 2.03
2014-09-30 $15.67B $7.48B 2.09
2014-06-30 $15.01B $7.26B 2.07
2014-03-31 $15.93B $8.03B 1.98
2013-12-31 $17.84B $5.81B 3.07
2013-09-30 $17.30B $5.53B 3.13
2013-06-30 $13.96B $5.49B 2.54
2013-03-31 $17.61B $7.43B 2.37
2012-12-31 $16.37B $7.05B 2.32
2012-09-30 $15.77B $6.20B 2.54
2012-06-30 $14.97B $9.08B 1.65
2012-03-31 $16.24B $9.55B 1.70
2011-12-31 $16.01B $13.25B 1.21
2011-09-30 $16.44B $13.12B 1.25
2011-03-31 $19.11B $5.26B 3.63
2010-03-31 $16.91B $4.61B 3.67
2009-09-30 $0.00B 0.00
2009-03-31 $15.06B $4.82B 3.13
2008-03-31 $22.44B $4.29B 5.23
2007-03-31 $19.98B $3.75B 5.33
2006-03-31 $20.27B $4.17B 4.86
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $56.939B $30.200B
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs. Takeda's core business comprise of ethical drugs and its portfolio includes lansoprazole for the treatment of peptic ulcers, leuprolide acetate for the treatment of prostate cancer and endometriosis, pioglitazone hydrocholoride for the treatment of diabetes, and candesartan cilexetil for the treatment of hypertension. The Company promotes enhancing R&D pipeline, while concentrating its management resources to the four core therapeutic areas: lifestyle-related diseases, oncology and urological diseases, central nervous system disease and gastroenterological diseases. It operates in two segments- Ethical drug business and Consumer healthcare business. Consumer healthcare business provides Alinamin (vitamin B1 derivative preparations, etc.), Benza (cold remedies). Takeda Pharmaceutical Company Limited is headquartered in Osaka, Japan.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.970B 41.96
Astellas Pharma (ALPMY) Japan $29.602B 18.49
Merck (MKGAF) Germany $22.933B 0.00
Eisai (ESALY) Japan $21.762B 18.96
UCB SA (UCBJF) Belgium $20.831B 0.00
Catalent (CTLT) United States $18.899B 56.53
Grifols, S.A (GRFS) Spain $13.235B 15.16
Neurocrine Biosciences (NBIX) United States $10.104B 79.52
Jazz Pharmaceuticals (JAZZ) Ireland $9.081B 14.67
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.772B 0.00
Ionis Pharmaceuticals (IONS) United States $8.340B 81.71
Arrowhead Pharmaceuticals (ARWR) United States $8.323B 0.00
United Therapeutics (UTHR) United States $7.204B 15.34
IPSEN SA ADR (IPSEY) France $7.040B 0.00
STADA ARZNEIMI (STDAF) Germany $6.884B 0.00
Orion OYJ (ORINY) Finland $6.427B 22.30
Evotec AG (EVTCY) Germany $5.853B 396.78
Sage Therapeutics (SAGE) United States $5.008B 0.00
PTC Therapeutics (PTCT) United States $4.547B 0.00
ChemoCentryx (CCXI) United States $4.271B 0.00
Hypermarcas (HYPMY) Brazil $4.117B 15.12
Cronos Group (CRON) Canada $3.807B 0.00
FibroGen (FGEN) United States $3.581B 0.00
Nektar Therapeutics (NKTR) United States $3.288B 0.00
Pacira BioSciences (PCRX) United States $3.193B 69.33
Corcept Therapeutics (CORT) United States $3.133B 30.30
Taro Pharmaceutical Industries (TARO) Israel $2.946B 15.04
Xencor (XNCR) United States $2.754B 0.00
Revolution Medicines (RVMD) United States $2.540B 0.00
Tilray (TLRY) Canada $2.006B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.804B 15.44
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.758B 0.00
Translate Bio (TBIO) United States $1.706B 0.00
Endo (ENDP) Ireland $1.663B 2.52
USANA Health Sciences (USNA) United States $1.660B 14.61
Heron Therapeutics (HRTX) United States $1.650B 0.00
Ocular Therapeutix (OCUL) United States $1.617B 0.00
Trillium Therapeutics (TRIL) Canada $1.465B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.439B 0.00
ImmunoGen (IMGN) United States $1.423B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.421B 9.88
Karyopharm Therapeutics (KPTI) United States $1.112B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.108B 0.00
Zogenix (ZGNX) United States $1.057B 0.00
Radius Health (RDUS) United States $1.029B 0.00
Indivior (INVVY) United States $1.029B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.937B 0.00
Vectura Group (VEGPF) United Kingdom $0.925B 0.00
Acutus Medical (AFIB) United States $0.794B 0.00
ORGANOGENESIS (ORGO) United States $0.791B 0.00
Collegium Pharmaceutical (COLL) United States $0.755B 44.55
Esperion Therapeutics (ESPR) United States $0.750B 0.00
VAXART, INC (VXRT) United States $0.742B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.719B 0.00
Aerie Pharmaceuticals (AERI) United States $0.668B 0.00
Chinook Therapeutics (KDNY) United States $0.652B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.634B 0.00
Ardelyx (ARDX) United States $0.626B 0.00
Flexion Therapeutics (FLXN) United States $0.580B 0.00
Siga Technologies (SIGA) United States $0.564B 15.85
Harpoon Therapeutics (HARP) United States $0.540B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.536B 0.00
Molecular Templates (MTEM) United States $0.533B 0.00
PROFOUND MEDICL (PROF) Canada $0.472B 0.00
Sundial Growers (SNDL) Canada $0.465B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.465B 0.00
Altimmune (ALT) United States $0.453B 0.00
Akebia Therapeutics (AKBA) United States $0.450B 0.00
Summit Therapeutics (SMMT) United States $0.436B 0.00
TherapeuticsMD (TXMD) United States $0.426B 0.00
DURECT (DRRX) United States $0.423B 0.00
CASI Pharmaceuticals (CASI) United States $0.404B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.391B 0.00
Rafael Holdings (RFL) United States $0.381B 0.00
Concert Pharmaceuticals (CNCE) United States $0.375B 0.00
Innate Pharma SA (IPHYF) France $0.371B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.365B 9.51
Matinas Biopharma Holdings (MTNB) United States $0.321B 0.00
MEI Pharma (MEIP) United States $0.316B 0.00
Alpine Immune Sciences (ALPN) United States $0.315B 0.00
Nature's Sunshine Products (NATR) United States $0.299B 19.23
Jaguar Animal Health (JAGX) United States $0.297B 0.00
KalVista Pharmaceuticals (KALV) United States $0.294B 0.00
Jounce Therapeutics (JNCE) United States $0.292B 0.00
Redhill Biopharma (RDHL) Israel $0.282B 0.00
Xeris Pharmaceuticals (XERS) United States $0.282B 0.00
Lannett Co Inc (LCI) United States $0.280B 7.37
Menlo Therapeutics (VYNE) United States $0.274B 0.00
Otonomy (OTIC) United States $0.271B 0.00
Aclaris Therapeutics (ACRS) United States $0.252B 0.00
CTI BioPharma (CTIC) United States $0.249B 0.00
OptiNose (OPTN) United States $0.222B 0.00
IMV INC (IMV) Canada $0.221B 0.00
Calithera Biosciences (CALA) United States $0.212B 0.00
Oncternal Therapeutics (ONCT) United States $0.199B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.194B 0.00
ProPhase Labs (PRPH) United States $0.182B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.180B 0.00
Aquestive Therapeutics (AQST) United States $0.178B 0.00
Infinity Pharmaceuticals (INFI) United States $0.171B 0.00
Taiwan Liposome (TLC) Taiwan $0.167B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.161B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.159B 0.00
IsoRay (ISR) United States $0.156B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.148B 0.00
Champions Oncology (CSBR) United States $0.148B 0.00
Heat Biologics (HTBX) United States $0.138B 0.00
Novan (NOVN) United States $0.137B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.135B 0.00
MediWound (MDWD) Israel $0.132B 0.00
Onconova Therapeutics (ONTX) United States $0.126B 0.00
Lipocine (LPCN) United States $0.101B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.100B 0.00
Nutriband (NTRB) United States $0.097B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.093B 0.00
SCYNEXIS (SCYX) United States $0.084B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.083B 0.00
Hemispherx BioPharma (AIM) United States $0.083B 0.00
Natural Alternatives (NAII) United States $0.079B 153.00
ElectroCore (ECOR) United States $0.076B 0.00
Biomerica (BMRA) United States $0.074B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.072B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.071B 0.00
Recro Pharma (REPH) United States $0.069B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.068B 0.00
India Globalization Capital (IGC) United States $0.067B 0.00
AgeX Therapeutics (AGE) United States $0.066B 0.00
CV Sciences (CVSI) United States $0.061B 0.00
Vical (BBI) United States $0.060B 0.00
Addex Therapeutics (ADXN) Switzerland $0.057B 0.00
Iterum Therapeutics (ITRM) Ireland $0.056B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.055B 0.00
RENEURON GP (RNUGF) United Kingdom $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.048B 24.77
Regulus Therapeutics (RGLS) United States $0.046B 0.00
PolarityTE (PTE) United States $0.045B 0.00
Neos Therapeutics (NEOS) United States $0.039B 0.00
Mannatechorporated (MTEX) United States $0.038B 5.58
NovaBay Pharmaceuticals (NBY) United States $0.038B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.036B 0.00
Can-Fite Biopharma (CANF) Israel $0.030B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.030B 0.00
KemPharm (KMPH) United States $0.027B 0.00
Midatech Pharma (MTP) United Kingdom $0.026B 0.00
China SXT Pharmaceuticals (SXTC) China $0.024B 0.00
Flex Pharma (SLRX) United States $0.024B 0.00
HANCOCK JAFFE (HJLI) United States $0.020B 0.00
Cyanotech (CYAN) United States $0.020B 33.00
Bellicum Pharmaceuticals (BLCM) United States $0.018B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
Xenetic Biosciences (XBIO) United States $0.017B 0.00
RXi Pharmaceuticals (PHIO) United States $0.017B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
Shineco (TYHT) China $0.011B 0.00
JanOne (JAN) United States $0.010B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00